If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
532.00    -2.00 (-0.37%)
Bid:
531.00
Ask:
533.00
Spread: 2.00 (0.377%)
Market Cap: £306.51m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Trading Update

31 Jan 2023 07:00

RNS Number : 3306O
Mortgage Advice Bureau (Hldgs) PLC
31 January 2023
 

31 January 2023

Mortgage Advice Bureau (Holdings) plc 

("MAB" or the "Group")

Trading Update 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1) today issues a trading update for the year ended 31 December 2022, ahead of publishing its final results on Tuesday, 28 March 2023.

The Group increased revenue for the year by 22% to circa £230m, despite the immediately negative impact of September's mini-budget on the mortgage market, with organic revenue growth of 10%. The acquisition of The Fluent Money Group ("Fluent") on 12 July 2022 added £22m of revenue. The Group's adjusted profit before tax for the year ended 31 December 2022 is expected to be in line with expectations.

The total number of Advisers at the year end was up 20% to 2,254(1) (2021: 1,885), including 182 advisers at Fluent, with the average number of mainstream(2) advisers during the year up 21% to 1,988 (2021: 1,649), representing organic growth of 15%. The number of mainstream advisers at the year end increased by 17% to 2,074 (2021: 1,774), with organic growth in mainstream advisers of 7%.

Following a leap in mortgage interest rates, the withdrawal of many mortgage products and a rapid tightening in lenders' underwriting criteria, Q4 saw significantly reduced house purchase and re-financing activity. Buy-to-Let activity was also significantly impacted. As a result of the sharp slowdown in all mortgage activity, most of our AR firms suspended adviser recruitment and reassessed their staffing requirements for 2023. This has resulted in cutbacks in advisers by some firms, particularly due to the significant short-term fall in purchase transactions requiring a mortgage.

After the Chancellor's Autumn Statement, mortgage rates stabilised and then improved a little towards the year end. The number of mortgages available also started to increase and this trend has strengthened into 2023. Although markets expect further rises in the Bank of England base rate, we expect lending conditions will continue to improve throughout 2023.

As anticipated, our congested pipeline of written new business started completing at a faster pace in Q4 due to lower new business levels freeing-up conveyancing capacity to process cases. We also expect this improving trend to continue through 2023. 

Current Trading and Outlook

Current activity levels are below the levels seen this time last year. However, towards the very end of this month there have been early signs of increasing lead volumes and written business across the Group, which we anticipate will build steadily as borrowers gain confidence in a more stable macroeconomic and interest rate environment.

UK Finance estimates that gross new mortgage lending for 2022 was £322bn (2021: £308bn). The Intermediary Mortgage Lenders Association and UK Finance's recent estimates of gross new mortgage lending for 2023 are £265bn and £275bn respectively, representing a 15% to 18% reduction versus 2022.

Although house purchase transactions will be lower this year, overall we expect a second-half weighted recovery. Re-financing opportunities from MAB's client bank are at a record level for 2023. In the wider market, 1.8 million borrowers' current mortgage deals will expire during 2023, providing further opportunity for MAB. It is forecast that Product Transfers will be a higher proportion of re-financing transactions than in prior years. We are ensuring our resources are deployed where our advisers and customers need them most, with lead generation continuing to be a major area of focus.

We expect to see a fall in adviser numbers in our current ARs during Q1 2023 as firms reduce their headcount in line with expected H1 2023 purchase activity. Lower lead levels result in a tightening of adviser numbers and an increased focus on maximising opportunities and productivity. However, we expect adviser numbers in our current ARs to stabilise in Q2 2023 and then build gradually in the second half as business volumes improve. We expect recruitment of new AR firms to be boosted by the quieter market and the tightening regulatory environment.

Despite the more challenging housing and mortgage market outlook for 2023, MAB's long term fundamentals remain very strong. We have taken a proactive and rigorous approach to costs, while progressing with the planned investment in our proposition to ensure the strongest possible recovery and market share growth in 2024 and beyond. Current trading is in line with expectations.

1 Includes a total of 180 advisers at 31 December 2022 who are later life advisers or advisers in directly authorised firms that use MAB's subsidiary, Auxilium, a specialist protection service provider, for protection. For both later life and directly authorised advisers the fees received by MAB represent the net income received by MAB as there are no commission payouts made by MAB.

2 Excludes directly authorised advisers, later life advisers and advisers from associates in the process of being onboarded under MAB's AR arrangements.

Peter Brodnicki, CEO of MAB, commented:

"Despite the uncertain macroeconomic outlook, MAB remains very well positioned to grow its market share strongly again through 2023. In times like these housing transactions are typically postponed, not lost, and the opportunity these conditions generate for new AR recruitment will benefit MAB in the medium term.

"The technology we have developed to help our AR firms optimise lead flow from existing lead sources and clients will help support an H2 recovery, and boost firm and adviser performance in all market conditions. Strong and effective lead flow has a heightened importance in times where purchase activity slows.

"We anticipate a very strong year ahead for re-financing, a slow but steady improvement in consumer confidence and housing transaction levels, combined with an increase in new AR recruitment and the incremental impact of new lead generation initiatives. I am confident that whilst continuing to grow market share this year, MAB will be in a very strong position to regain significant momentum in 2024."

Enquiries:

Mortgage Advice Bureau (Holdings) plc +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Lucy Tilley, Chief Financial Officer

Nominated Adviser and Joint Broker +44 (0)20 7260 1000

 

Numis Securities Limited

Stephen Westgate / Giles Rolls

Joint Broker:

Peel Hunt LLP

Andrew Buchanan / Mike Burke +44 (0) 20 7418 8900

 

Media Enquiries:

investorrelations@mab.org.uk

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR"). 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFVFLVIIVIV
Date   Source Headline
31st Oct 20183:35 pmRNSDirector/PDMR Shareholding
29th Oct 20189:13 amRNSDirector/PDMR Shareholding
23rd Oct 20187:00 amRNSHolding(s) in Company
17th Oct 20187:00 amRNSReplacement: Director/PDMR Shareholding
16th Oct 20187:00 amRNSDirector/PDMR Shareholding
4th Oct 20182:24 pmRNSHolding(s) in Company
4th Oct 20188:11 amRNSHolding(s) in Company
28th Sep 20182:16 pmRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSHalf-year Report
14th Sep 20184:43 pmRNSDirector/PDMR Shareholding
14th Sep 20187:00 amRNSChange of Adviser
31st Aug 201811:08 amRNSDirector/PDMR Shareholding
28th Aug 20184:10 pmRNSHolding(s) in Company
14th Aug 20183:13 pmRNSDirector/PDMR Shareholding
2nd Aug 201812:07 pmRNSSecond Price Monitoring Extn
2nd Aug 201812:02 pmRNSPrice Monitoring Extension
31st Jul 20185:05 pmRNSDirector/PDMR Shareholding
26th Jul 20187:00 amRNSPre-close Trading Update
16th Jul 20182:34 pmRNSDirector/PDMR Shareholding
2nd Jul 20186:43 pmRNSHolding(s) in Company
2nd Jul 20186:43 pmRNSHolding(s) in Company
29th Jun 20185:06 pmRNSDirector/PDMR Shareholding
14th Jun 20185:28 pmRNSDirector/PDMR Shareholding
7th Jun 20187:00 amRNSBoard Appointment
31st May 20186:16 pmRNSDirector/PDMR Shareholding
23rd May 20184:08 pmRNSDirector/PDMR Shareholding
17th May 20183:10 pmRNSResult of AGM
17th May 201810:31 amRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSAGM Statement
15th May 20187:00 amRNSDirector/PDMR Shareholding
30th Apr 20184:34 pmRNSDirector/PDMR Shareholding
17th Apr 20182:08 pmRNSPosting of Report and Accounts & Notice of AGM
16th Apr 20183:49 pmRNSDirector/PDMR Shareholding
10th Apr 20186:20 pmRNSGrant of options and Director dealing
6th Apr 20187:00 amRNSDirector/PDMR Shareholding
4th Apr 20187:00 amRNSBoard Appointment
29th Mar 20183:23 pmRNSDirector/PDMR Shareholding
28th Mar 20187:26 amRNSBlock Admission Application
20th Mar 20187:00 amRNSFinal Results for the year ended 31 December 2017
15th Mar 20189:38 amRNSDirector/PDMR Shareholding
28th Feb 20184:00 pmRNSDirector/PDMR Shareholding
15th Feb 20188:07 amRNSDirector/PDMR Shareholding
31st Jan 20186:15 pmRNSDirector/PDMR Shareholding
22nd Jan 20187:00 amRNSPre-close Trading Update
15th Jan 20183:31 pmRNSDirector/PDMR Shareholding
8th Jan 20188:56 amRNSNon-Executive Director Board changes
28th Dec 20177:00 amRNSDirector/PDMR Shareholding
14th Dec 20175:59 pmRNSDirector/PDMR Shareholding
30th Nov 20174:23 pmRNSDirector/PDMR Shareholding
14th Nov 20174:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.